Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Durvalumab 1500 / Cisplatin 70 / Gemcitabine 1000, Bladder Cancer, neoadjuvant, cycle 1-4

Protocol-ID: 2718 V1.0 (Mini), DURV1500/CISP70/GEMC1000, Bladder Cancer, neoadj., C1-4

Indication(s)

  • Bladder Cancer; ICD-10 C67.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 08.10.2024